Skip to content
Daily Fruit Lab

Patients Discontinuing Slimming Medications Gain Back Weight Four Times Faster Than Dieters

Image of pharmaceutical syringe and scale
Obesity treatment often requires ongoing approaches.

Fresh analysis reveals that people who discontinue popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight much more quickly than those who halt conventional diet and exercise regimens.

Research printed in a leading health publication demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month once they quit.

"People buying these treatments need to be cognizant of the danger of fast weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

Such speed of regain implies a return to original weight in about 18 months.

Weighing Approaches

The research, which looked at 37 of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.

Researchers point out that people who lose weight through dieting typically have a slower weight regain—approximately 100 grams monthly—after stopping.

The Reason for the Fast Regain

Doctors suggest the mode of action of the drugs is key to understanding the accelerated rebound.

GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone concentrations several times higher than normal could lead to the system to produce less of its own natural GLP-1, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this GLP-1 'fix' leads to hunger is no longer kept in check, making overeating far more likely."

An Ongoing Condition?

Medical guidelines suggest the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.

A number of clinicians contend that, considering the significant potential of weight regain, the therapy should be considered ongoing.

This opinion is reinforced by drug manufacturers, who say that the results "emphasize the long-term nature of excess weight," similar to managing diseases like hypertension.

User Testimonies

Users who have stopped the jabs explain a intense return of appetite.

"It was like a switch activating and you're instantly ravenous," described an individual.

This challenge is worsened if individuals have not developed sustainable lifestyle or habit modifications during therapy.

Widespread Interest

Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand being substantial.

  • Use is greater among women compared to men.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion access the drugs through private healthcare rather than the NHS.

Ultimately, clinicians emphasize that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and maintained weight loss hinges on ongoing behavioural support.

GS
About the author

Grant Salazar

Elena is a certified nutritionist and food science writer with a passion for making healthy eating simple and enjoyable.

Daily Fruit Lab

Type to search articles.